US43906K2096 - Common Stock
HOOKIPA PHARMA INC
NASDAQ:HOOK (10/22/2024, 1:17:08 PM)
3.99
0 (0%)
HOOKIPA Pharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 151 full-time employees. The company went IPO on 2019-04-18. HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The firm is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
HOOKIPA PHARMA INC
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York City NEW YORK 10118
P: 114318906360
CEO: Joern Aldag
Employees: 165
Website: https://www.hookipapharma.com/
Preclinical proof-of-concept package to be presented at Industry Summit on RAS being held September 24-26, 2024
Preclinical proof-of-concept package to be presented at Industry Summit on RAS being held September 24-26, 2024...
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a company developing a new class...
NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of...
Here you can normally see the latest stock twits on HOOK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: